scispace - formally typeset
Journal ArticleDOI

Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients.

TLDR
The findings of erythroid maturation and abundant viral inclusions in these immunocompromised patients is consistent with the hypothesis that failure to produce effective IgG parvovirus neutralizing antibodies may lead to persistent infection through viral tolerance that allows erythyroid development of infected cells past the pronormoblast stage.
About
This article is published in Human Pathology.The article was published on 2000-02-01. It has received 28 citations till now. The article focuses on the topics: Parvovirus infection & Parvovirus.

read more

Citations
More filters
Journal ArticleDOI

Human Parvovirus B19

TL;DR: Parvovirus B19 was discovered in 1974 and is the only member of the family Parvoviridae known to be pathogenic in humans, anddiagnosis is primarily based on detection of specific antibodies by enzyme-linked immunosorbent assay or detection of viral DNA by dot blot hybridization or PCR.
Journal ArticleDOI

Parvovirus B19 in pregnancy.

TL;DR: Since Parvovirus B19 infection should be part of the routine work up of complicated pregnancies, risk assessment for maternal infection during pregnancy is especially important during epidemics when sero-conversion rates are high.
Journal ArticleDOI

Parvovirus-B19-associated complications in renal transplant recipients

TL;DR: The most common manifestations of B19 infection in immunosuppressed patients are pure red cell aplasia and other cytopenias, and this diagnosis should be considered in transplant recipients with unexplained anemia and reticulocytopenia or pancy topenia.
Journal ArticleDOI

Fifth (human parvovirus) and sixth (herpesvirus 6) diseases.

TL;DR: The relationship between the viruses and these conditions remains controversial, and better diagnostic tests and further information on viral pathogenesis for both viruses are required in order to make a reliable judgment in this regard.
Journal ArticleDOI

Direct Ex Vivo Measurement of CD8+T-Lymphocyte Responses to Human Parvovirus B19

TL;DR: The mapping of the first parvovirus B19-derived CD8+ T-lymphocyte epitope is described, which derives from the nonstructural (NS1) protein and is strongly immunogenic in B19 virus-seropositive donors.
References
More filters
Journal ArticleDOI

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

TL;DR: The B19 parvovirus is a remediable cause of severe chronic anemia in HIV-infected patients and recognition of and therapy for parVovirus in this population will avoid erythrocyte transfusion and should prevent transmission of the virus to other persons, including immunosuppressed persons and women of child-bearing age.
Journal ArticleDOI

Chronic bone marrow failure due to persistent B19 parvovirus infection.

TL;DR: The B19 parvovirus, which was serendipitously discovered in serum from blood-bank donors in 1975, has been associated with several human illnesses and is the etiologic agent of the common childhood exanthem called fifth disease.
Journal ArticleDOI

Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.

TL;DR: In tissue-culture studies, parvovirus B19 is the etiologic agent of transient aplastic crisis, an acute episode of bone marrow failure in persons with underlying hemolysis.
Journal ArticleDOI

Human parvovirus infection in pregnancy and hydrops fetalis.

TL;DR: It is concluded that this common virus may pose a serious risk to the fetus after maternal infection in women with serologic evidence of having contracted human parvovirus infection during pregnancy.
Related Papers (5)